PRTA - Prothena Corporation plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
752
955
27,519
1,055
1,607
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
1,607
Operating Expenses
Research Development
51,875
101,183
134,547
119,534
58,439
Selling General and Administrative
35,703
42,482
48,226
41,056
23,105
Total Operating Expenses
87,578
143,665
182,773
160,590
81,544
Operating Income or Loss
-86,826
-142,710
-155,254
-159,535
-79,937
Interest Expense
936
3,697
-
-
-
Total Other Income/Expenses Net
1,799
-16,097
-2,207
15
26
Income Before Tax
-77,523
-156,115
-157,603
-158,964
-79,911
Income Tax Expense
1,061
-470
-4,366
1,144
701
Income from Continuing Operations
-78,584
-155,645
-153,237
-160,108
-80,612
Net Income
-78,584
-155,645
-153,237
-160,108
-80,612
Net Income available to common shareholders
-78,584
-155,645
-153,237
-160,108
-80,612
Reported EPS
Basic
-
-3.93
-4.07
-4.66
-2.66
Diluted
-
-3.93
-4.07
-4.66
-2.66
Weighted average shares outstanding
Basic
-
39,559
37,654
34,351
30,326
Diluted
-
39,559
37,654
34,351
30,326
EBITDA
-
-149,202
-152,187
-157,108
-79,937